trial

Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features

NCTId NCT00202293
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Completed
Enrollment 83 (actual)
Sponsored by Melbourne Health
Primary completion 2015-11-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Completed
Enrollment
83 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2001-10-01
Primary completion
2015-11-01
Eligibility
ALL · 15 Years · 29 Years

Interventions & indications

Drugs
OlanzapineLithiumChlorpromazine

Sponsors

Melbourne HealthLead Sponsor

Investigators

1
Philippe ConusPrincipal Investigator

Sites

1 total
Parkville, Australia

Facts & assertions

4 sourced
Enrollment
83
Phase
PHASE4
Primary Completion Date
2015-11-01
Status
COMPLETED
relationships
The graph out of here
drug
Olanzapine
drug
Lithium
drug
Chlorpromazine
drug
lead_sponsor
Melbourne Health
company
indication
Mania
indication
Bipolar Disorder
indication
Schizoaffective Disorder
indication
investigator
Philippe Conus
person